Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

MWI Animal Health Acquires Regional Veterinary Wholesaler, Northeast Veterinary Supply Company

12/12/2017 | 08:07am EDT

New business acquisition highlights AmerisourceBergen and MWI Animal Health’s focus on support of veterinary practices

Today, MWI Animal Health, a part of AmerisourceBergen, announced the acquisition of Northeast Veterinary Supply Co. (NEVSCO), an independent, regional distributor of veterinary pharmaceuticals and medical supplies servicing primarily the northeast region of the U.S. The acquisition of NEVSCO continues to strengthen MWI’s position to better support the viability of independent veterinary practices and provide even greater value and care to current and future animal health customers.

“At MWI, we’re focused on providing veterinary practices with the tools and resources they need to compete in a dynamic animal health marketplace,” said Mark Shaw, President of MWI Animal Health. “The acquisition of NEVSCO is just another demonstration of this mission and together we look forward to building on the value NEVSCO has provided to their customers. We want to combine the best of both organizations to create the most valuable distribution network serving companion animal veterinarians in the northeast.”

NEVSCO has an excellent reputation for outstanding customer service and the ability to provide comprehensive, personalized solutions to best meet the evolving needs of independent veterinary practices so clients can focus on clinical care. This acquisition will provide NEVSCO customers with access to an expanded product portfolio, as well as access to MWI’s industry-leading e-commerce platform and practice-building programs.

To learn more about MWI Animal Health, visit www.mwiah.com.

About AmerisourceBergen

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 20,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $150 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.


ę Business Wire 2017
Latest news "Companies"
09:45aRollins Names Interim Finance Chief Amid SEC Probe -- Update
DJ
09:44aIPSEN : strengthens its pre-clinical Oncology pipeline with an exclusive worldwide-collaboration with BAKX Therapeutics Inc. for BKX-001 targeting the apoptosis pathway
AQ
09:44aCIDARA THERAPEUTICS : To present new data for rezafungin at the international society for human and animal mycology asia congress
AQ
09:44aMERCK : Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival in Patients with Metastatic Triple-Negative Breast Cancer Whose Tumors Expressed PD-L1
AQ
09:44aBRAINSTORM CELL THERAPEUTICS : Increases Commercial Manufacturing Capacity Granted GMP Certification for a Second Production Site in Israel
AQ
09:44aDEVONIAN HEALTH : Heath Group Inc. to Participate in Renmark's Virtual Non-deal Roadshow Series in Chicago Today July 27, 2021
AQ
09:44aRAPID DOSE THERAPEUTICS : Provides Bi Weekly Status Report Regarding Management Cease Trade Order
AQ
09:44aBRIDGEBIO PHARMA : Announces Clinical Collaboration With Bristol Myers Squibb To Study BBP-398 A Potentially Best-In-Class SHP2 Inhibitor In Combination With OPDIVO In Advanced Solid Tumors With KRAS Mutations
AQ
09:44aAC IMMUNE : Announces Strategic Acquisition of Industry-leading Parkinson's Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH
AQ
09:44aDEVONIAN HEALTH : Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder
AQ
Latest news "Companies"